Patients with a hip fracture who are given DAPT with ASA and thienopyridine because of recent coronary artery stenting are at high risk for developing stent thrombosis, if DAPT is discontinued prematurely.
Patients with stent thrombosis have a mortality rate of 50% and higher.
Always consult the attending cardiologist and use an interdisciplinary approach: the risk of major intraoperative bleeding has to be weighed against the risk of stent thrombosis.
The following concept seems to be appropriate in many cases.
<%= buttons %>